Nuclear medicine imaging of lung cancer.

[1]  E. van Marck,et al.  Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging. , 1997, The European respiratory journal.

[2]  H. Tonami,et al.  Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  L. Mortelmans,et al.  FDG-PET in the Locoregional Lymph Node Staging of Non-small Cell Lung Cancer. A Comprehensive Review of the Leuven Lung Cancer Group Experience. , 1999, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[4]  David J. Yang,et al.  Detecting recurrent or residual lung cancer with FDG-PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  R. Coleman,et al.  Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. , 1993, Radiology.

[6]  T Jones,et al.  Glucose utilization in vivo by human pulmonary neoplasms , 1987, Cancer.

[7]  J. Gurney.  Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part I. Theory. , 1993, Radiology.

[8]  G. V. von Schulthess,et al.  Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. , 1997, Radiology.

[9]  V. Lowe,et al.  Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings. , 1996, American Journal of Clinical Oncology.

[10]  N. Müller,et al.  Solitary pulmonary nodule: high-resolution CT and radiologic-pathologic correlation. , 1991, Radiology.

[11]  T. Turkington,et al.  FDG imaging of lung nodules: a phantom study comparing SPECT, camera-based PET, and dedicated PET. , 1999, Radiology.

[12]  R. Wahl.  Targeting glucose transporters for tumor imaging: "sweet" idea, "sour" result. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  B. Långström,et al.  Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  W. T. Sullivan,et al.  Transbronchial needle aspiration staging of bronchogenic carcinoma. , 2015, The American review of respiratory disease.

[15]  C. Bolliger,et al.  Transbronchial needle aspiration in routine fiberoptic bronchoscopy. , 1992, Respiration; international review of thoracic diseases.

[16]  D. Naidich,et al.  Solitary Pulmonary Nodules: CT-Bronchoscopic Correlation , 1988 .

[17]  P. Valent,et al.  Tc-p829 99m of a Novel Tumor Tracer, Binding in Vivo Somatostatin Receptor Subtype Specificity and Updated Version Citing Articles E-mail Alerts Somatostatin Receptor Subtype Specificity and in Vivo Binding of a Novel Tumor Tracer, 99mtc-p8291 , 2013 .

[18]  J. Gurney,et al.  Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part II. Application. , 1993, Radiology.

[19]  R L Wahl,et al.  Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT. , 1999, Radiology.

[20]  R. Wahl,et al.  Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. , 1994, Radiology.

[21]  R. Coleman,et al.  Pulmonary abnormalities and PET data analysis: a retrospective study. , 1997, Radiology.

[22]  P. Marsden,et al.  Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer , 1994, The Lancet.

[23]  R Iwata,et al.  Differential diagnosis of lung tumor with positron emission tomography: a prospective study. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  T. Rice,et al.  Solitary pulmonary nodule. , 1988, Cleveland Clinic journal of medicine.

[25]  M P Frick,et al.  Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. , 1993, Chest.

[26]  D Delbeke,et al.  Prospective investigation of positron emission tomography in lung nodules. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  V. Lowe,et al.  Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose. , 1994, Radiology.

[28]  J. Blum,et al.  The utility of a somatostatin-type receptor binding peptide radiopharmaceutical (P829) in the evaluation of solitary pulmonary nodules. , 1999, Chest.

[29]  E. Gunel,et al.  Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  D. Delbeke,et al.  Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy. , 1996, Chest.

[31]  P. Valk,et al.  Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. , 1995, The Annals of thoracic surgery.

[32]  N. Gupta,et al.  PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis. , 1995, Chest.

[33]  B J McNeil,et al.  CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. , 1991, Radiology.